Lumida
/HROW
⌘K
Harrow Inc

Harrow Inc

HROW
$34.48USD-5.74%-2.10 today

MARKET CAP

1.3B

P/E (TTM)

FWD P/E

DAY RANGE

$34 – $37

52W RANGE

$29
$55

AI Summary

Stalk
TrimMedium

The stock is in a Stage 4 decline with active lower highs/lower lows and a Bearish Pivot Point indicating failed upside control. Price remains below declining short-term EMAs and the 50 SMA, but proximity to immediate support and neutral RSI suggest a potential pause or bounce, making deferred selling preferred until resistance is retested.

  • IHEEZO trial shows 58% lower injection discomfort vs peers
  • Revenue to grow at 28.2% CAGR, aiming profitability by 2027
  • Negative earnings yield and –37.3 P/E highlight valuation strain
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$72.5M$88.6M$130.2M$199.6M$272.3M
YoY %+48.3%+22.2%+47.0%+53.3%+36.4%
P / Sales3.2x4.6x3.0x6.0x6.6x
EV / Sales3.8x5.0x4.3x7.4x7.6x
Gross Profit, Adj.$54.3M$63.2M$90.6M$150.4M$204.4M
YoY %+57.7%+16.5%+43.3%+66.1%+35.9%
Margin %74.9%71.3%69.6%75.3%75.1%
EV / Gross Profit5.1x7.0x6.2x9.8x10.2x
EBITDA, Adj.$3.7M$5.6M$12.4M$22.7M$49.4M
YoY %-2.9%+49.3%+122.5%+82.8%+117.6%
Margin %5.2%6.3%9.5%11.4%18.1%
EV / EBITDA73.9x78.8x44.9x64.7x42.0x
EBIT$1.6M$1.9M$431,000$8.8M$30.5M
YoY %+319.2%+18.9%-77.5%+1946.9%+245.9%
Margin %2.2%2.2%0.3%4.4%11.2%
EV / EBIT171.3x229.2x1293.4x166.5x68.0x
Net Income$-18.5M$-14.1M$-24.4M$-17.5M$-5.1M
YoY %-450.5%+23.8%-73.3%+28.4%+70.6%
Net Margin-25.5%-15.9%-18.7%-8.8%-1.9%
EPS (GAAP)-$0.69-$0.51-$0.75-$0.49-$0.14
YoY %-430.8%+26.1%-47.1%+34.7%+71.4%